Latest Post

Summary – – Tiziana is Developing the First Oral Form of Foralumab in a Convenient Capsule to be Evaluated in Phase 1b Clinical Study Tiziana Life Sciences Ltd (Nasdaq: TLSA) …

Summary : Liver cancer, also known as hepatic cancer and primary hepatic cancer, is a relatively rare form of cancer that has a high mortality rate. As with other cancers, …

Synopsis : mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus will also be speaking at SCOPE 2022 on …

Summary : A good news is brewing for kids as the COVID-19 vaccine for the age group younger than 5 years old will be made available in the US sooner …

Summary : Fast Radius will trade on Nasdaq under ticker symbol “FSRD” “Fast Radius”), a cloud manufacturing company, today announced the successful closing of its previously announced business combination with …

Synopsis : ION Geophysical Corporation (NYSE: IO) today announced that it received notice on January 31, 2022 from the New York Stock Exchange (the “NYSE”) that the price of its …

Summary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment to decrease the need for red blood cell …

Synopsis : Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced the grant to two employees …

Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for areas such as diabetes and cardiovascular diseases. After …

Synopsis : Novartis reported its full-year financials this week for 2021, and overall, the news was good. Full-year net sales grew 4%, fourth-quarter sales were up 6% and operating income …

Summary – The House Energy and Commerce Committee’s health panel met to discuss renewing user fee agreements used to fund the U.S. Food and Drug Administration. To many observers’ surprise, …

Synopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive Phase 2 data for their Lyme disease vaccine …

Summary : Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is capable of neutralizing even Omicron after a total …

Summary : Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today that it has executed agreements selling its wholly-owned subsidiary that holds a 25 percent equity interest in …

Summary : OceanFirst Financial Corp. (NASDAQ:”OCFC”), (the “Company”), the holding company for OceanFirst Bank N.A. (the “Bank”), today, announced the Company has signed an agreement to acquire a majority interest in …

Summary : -As Australians gear up for the further reopening of international travel lanes in 2022, proof of COVID-19 vaccination is a necessity. -To provide this proof, Verizon Business Australia …

Global Crossing Airlines Group, Inc. (JET: TSX-V; JET.B: TSX-V; JETMF: OTCQB) (the “Company” or “GlobalX”) today announces that, on February 3, 2022 the Company filed a Form 8-A Registration Statement (“Form …

Summary : First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England Two children with early-onset MLD recently treated commercially with Libmeldy in Germany and France A …

Summary : On Thursday, Mersana Therapeutics signed a research and licensing deal with Janssen Biotech to access each other’s proprietary technology in discovering new antibody-drug conjugates (ADCs) for three cancer …

Synopsis : A $1.5 billion diabetes partnership between Eli Lilly and China-based Regor Therapeutics Group is at the center of a lawsuit filed by Pfizer, claiming that the founders of …

Synopsis : A new study published in the journal Nature found that two patients with leukemia who were treated with CAR T-cell therapy are still in remission 10 years later. …

Summary : Featuring nine of the most important regions in the life sciences industry, BioSpace’s Hotbed Maps are the guide employees and investors across the sector look to in order …

Summary : Amgen (NASDAQ:AMGN) and Plexium, Inc. (Plexium) today announced an exclusive, worldwide, multi-year research collaboration and license agreement to identify novel targeted protein degradation therapeutics toward historically challenging drug …

Summary :  A new option for those affected by keratoconjunctivitis sicca. The FDA approved the first generic of cyclosporine ophthalmic emulsion (Restasis) for dry eye, a condition that affects millions …

Summary : This week, Gilead Sciences took a $1.25 billion hit after reaching a settlement with ViiV Healthcare on a patent dispute involving the human immunodeficiency virus (HIV) drug dolutegravir. …

Synopsis : A powerful class of antibiotics called carbapenems can circumvent antibiotic resistance thanks to a particular chain of atoms in their structure. Now, a team of researchers from Penn …

Summary : Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the conditional …

A highly mutated version of SARS-CoV-2, the virus that causes COVID-19, the Omicron variant has been shown to cause breakthrough infections among the vaccinated thanks to its ability to evade …

Synopsis : The Budget had reduced cooperatives’ alternate minimum tax and charge. Meenesh Shah, Chairman, National Dairy Development Board had welcomed the reduction in alternate minimum tax for cooperative from …

Synopsis : The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in …

Summary : Budget 2022 India Live, FM Nirmala Sitharaman Speech Live Updates: Speaking at a press conference after presenting the Union Budget, Finance Minister Nirmala Sitharaman said a conscious decision …

The prior authorization process often involves complex transactions and increases the burden not only on physicians and pharmacies, but can also impact patient access. Drug pricing and reimbursement is a …

Summary : In a clinical trial, the median annualized bleeding rates for all bleeds was reduced from a historical median of 5 to an on-study median of 2.3, which is …

Synopsis : ViiV Healthcare’s HIV treatment Cabenuva has been approved by the U.S. Food and Drug Administration for use every two months, meaning patients only have to receive an injectable …

Synopsis :: -ImmunityBio shared positive results from the clinical trial of its IL-15 superagonist Anktiva (N-803) to treat people living with human immunodeficiency virus (HIV). -The Phase I HIV Cure …

Summary : Panacea Biotec Pharma is a subsidiary of vaccine maker Panacea Biotec; its domestic biz had a turnover of Rs 219 cr in FY21; Adar Poonawalla holds 8.6% stake …

Synopsis : Autonomous vehicle industry veteran will build on early success to lead operational growth, oversee geographic expansion, and spearhead Embark’s commercialization effort. Embark Trucks, Inc. (Nasdaq: EMBK, “Embark”), a …

Summary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program for cardiovascular (CV) risk reduction and severe hypertriglyceridemia (SHTG), or high triglycerides. Pfizer was leading …

Synopsis : Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, announced today that Dr. Dominic F. Labriola has joined Madrigal as Senior Vice President …

Synopsis : Shares of Madrigal Pharmaceuticals went up in premarket trading after the company announced positive topline data from its Phase III assessment of resmetirom in non-alcoholic fatty liver disease. …

Summary : One week after Johnna Rossell departed Biogen for Enzyvant, the embattled company announced that two members of its board of directors are leaving. Nancy Leaming and Brian Posner …

Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax …

Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir was active against the fast-spreading Omicron variant. The …

Synopsis : Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed salts indicated for the treatment of Attention Deficit …

Summary : String Bio, a Bengaluru-based company, has developed a platform for converting methane into various solutions such as biostimulants for crops, animal feed, and alternative protein for human consumption …

Summary : Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized medicine, announced today that it was terminating its previously announced rights offering and the …

Synopsis : Biogen is selling its nearly 50% stake in South Korea-based Samsung Bioepis for $2.3 billion. The move will provide Biogen with additional capital while preparing to cut additional …

  Courtesy of Alzamend Neuro On the strength of data from its Phase 1 Study  of lead compound, AL001, being developed for the treatment of Alzheimer’s disease, Alzamend Neuro is looking …

Summary : Oxford Biomedica and Homology Medicines to establish Oxford Biomedica Solutions LLC, a new U.S.-based AAV Manufacturing and Innovation Business Homology Medicines to receive $130 million from Oxford Biomedica …

Executive Summary The pharma also warns that an FDA complete response letter could be coming for its supplemental NDA to add atopic dermatitis to the JAK1 inhibitor’s label. Olumiant’s list …